SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-20-000099
Filing Date
2020-09-14
Accepted
2020-09-14 16:02:38
Documents
1
Period of Report
2020-09-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160011374518224.html 4  
1 FORM 4 wf-form4_160011374518224.xml 4 3710
  Complete submission text file 0001600132-20-000099.txt   5206
Mailing Address C/O BELLEROPHON THERAPEUTICS 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address
Bruder Scott P (Reporting) CIK: 0001411721 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 201173202

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations